Cao [96, 97] found that The granule of the KXYA formula treated HBV-related liver cancer by regulating the expression of genes such as MAPK8, HDAC1, PTEN, NR3C1, EGFR and HNF4A. This evidence concerns the gene EGFR and liver cancer.